Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: This study set out to determine the incidence of hypoglycemia in patients with chronic kidney disease (CKD), with and without diabetes, and the association of hypoglycemia with mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a retrospective cohort analysis of 243,222 patients who had 2,040,206 glucose measurements and were cared for at the Veterans Health Administration. CKD was defined as an estimated GFR of <60 ml/min per 1.73 m(2). Hypoglycemia was set at <70 mg/dl. Mortality was measured 1 day after glucose measurement. RESULTS: The incidence of hypoglycemia was higher in patients with CKD versus without CKD. Among patients with diabetes, the rate was 10.72 versus 5.33 per 100 patient-months and among patients without diabetes was 3.46 versus 2.23 per 100 patient-months, for CKD versus no CKD, respectively. The odds of 1-d mortality were increased at all levels of hypoglycemia but attenuated in CKD versus no CKD. Adjusted odds ratios for 1-d mortality that were associated with glucose values of <50, 50 to 59, and 60 to 69 mg/dl, respectively, versus glucose of >or=70 mg/dl were 6.09, 4.10, and 1.85 for inpatient records from patients with CKD; 9.95, 3.79, and 2.54 for inpatients records from patients without CKD; 6.84, 3.28, and 3.98 for outpatient records from patients with CKD; and 13.28, 7.36, and 4.34 for outpatient records from patients without CKD. CONCLUSIONS: CKD is a risk for hypoglycemia, with or without diabetes. The excessive mortality associated with hypoglycemia makes this complication a significant threat to patient safety in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CKD is a risk factor for non-diabetic hypoglycemia, as reflected in significantly higher hypoglycemia rates in patients with CKD compared to patients without CKD (3.46 vs. 2.23/100 patient-months, p < 0.0001) [29].”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Both the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) and the Veterans Affairs Diabetes Trial (VADT) found that severe hypoglycemia was more common in an intensive glucose-lowering group than a control group, but the two treatment groups had similar m…”
BackgroundMethodInfluential(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559 · cited 1×
“The selection of these cut points was derived from definitions of hypoglycemia used in previous studies (5, 17 ,18), but because none of them was used exclusively, we elected to incorporate all of them as measures of hypoglycemic severity.”
MethodMechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia
Robinson, R. T. C. E., Harris, N. D., Ireland, R. H., Lee, S., Newman, C., & Heller, S. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1469 · Cited by 264 · cited 2×
“In addition, acute hypoglycemia can result in a surge in adrenergic activity, which can result in coronary ischemia, serious cardiac arrhythmias, and sudden death (7).”
BackgroundValidation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Ginde, A. A., Blanc, P. G., Lieberman, R. M., & Camargo, C. A. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-4 · Cited by 234
Snyder, R. W., & Berns, J. S. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17346.x · Cited by 215
Research works printed but not linked: 1
- [6]Berlin KS, Sass DA, Davies WH, Reupert S, Hains AA: Brief report: Parent perceptions of hypoglycemic symptoms in youth with diabetes. J Pediatr Psychol 30: 207–212, 2005 [DOI] [PubMed] [Google Scholar]
Cited by
Items 201–300 of 428
Samuel, S., Goswami, D., Shum, K., Boye, K. S., Rengarajan, B., Curtis, B. H., & Curtis, S. E. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1020363 · Cited by 13
“The result is based on Moen et al.50, who found that the ratio of hypoglycemia for those with chronic kidney disease stage 3 (CKD3) to those without CKD3 was independent of three plasma glucose brackets of 605glucose570 mg/dL, 505glucose 560 mg/dL, and glucose550 mg/dL, which suggests that the relative risk due to CKD…”
MethodPathophysiological Ramifications of Diabetic Condition: A Review
Shahi, A., Vss, P., Imam, S. S., Muheem, A., & Jahangir, M. A. (2018) · Asian journal of biomedical and pharmaceutical sciences · doi:10.4066/2249-622x.65.18-845 · Cited by 15
Dalbhi, S. A., ALEissa, M., ALGHOFAILI, I. A., Alotaibi, H. F., Yaslam, M., AlMujil, M., & Arnous, M. M. (2020) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_304_19 · Cited by 18
“[18,26,27] Besides, hypoglycemia may contribute to the high cardiovascular morbidity and mortality observed in individuals with CKD.[21,28,29]”
BackgroundHumphrey, T. J. L., James, G., Wilkinson, I. B., & Hiemstra, T. F. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.09.018 · Cited by 14
Tanaka, K., Okada, Y., Mori, H., Inada, Y., Suzuka, K., Uriu, K., & Tanaka, Y. (2016) · Diabetology International · doi:10.1007/s13340-016-0258-y · Cited by 13
Yang, C., Lin, W., Li, L., Ou, H., & Kuo, S. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2262 · Cited by 14
“SUs are supporting evidence for the rational use of DPP4is in patients with T2D and advanced CKD, who are more vulnerable to hypoglycemic events compared with the general T2D population.(38) The potential benefit of reducing all- cause mortality associated with DPP4is vs.”
BackgroundA Varying Patient Safety Profile Between Black and Nonblack Adults With Decreased Estimated GFR
Diamantidis, C. J., Seliger, S. L., Zhan, M., Walker, L. D., Rattinger, G. B., Hsu, V. D., & Fink, J. C. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.01.023 · Cited by 12
Self-citationUpdate on Glycemic Control for the Treatment of Diabetic Kidney Disease
Nadkarni, G. N., Yacoub, R., & Coca, S. G. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0612-7 · Cited by 13
Rhee, C. M., Kovesdy, C. P., Ravel, V., Streja, E., Sim, J. J., You, A. S., Gatwood, J. D., Amin, A., Molnar, M. Z., Nguyen, D. V., et al. (2018) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2018.07.003 · Cited by 13
Olsen, V. D. R., Borges, F. K., Goldraich, L. A., Hastenteufel, L. C. T., Amantéa, R. P., Leitão, S. A. T., Manfro, R. C., & Clausell, N. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100908 · Cited by 12
Munch, M., Meyer, L., Hannedouche, T. P., Kunz, K., Alenabi, F., Winiszewski, P., Baltzinger, P., Smagala, A., Klein, A., Dorey, F., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13988 · Cited by 13
Gnudi, L. (2022) · La Presse Médicale · doi:10.1016/j.lpm.2022.104159 · Cited by 12
Balkau, B., Metzger, M., Andréelli, F., Frimat, L., Speyer, É., Combe, C., Laville, M., Jacquelinet, C., Briançon, S., Ayav, C., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.03.007 · Cited by 13
Managing care for people with diabetes undergoing dialysis
Gregory, S., & Jenkins, K. (2019) · Journal of Renal Care · doi:10.1111/jorc.12266 · Cited by 13
Runesson, B., Xu, Y., Qureshi, A. R., Lindholm, B., Barany, P. F., Elinder, C. G., & Carrero, J. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14051 · Cited by 11
“However, studies of the incidence and severity of hypoglycaemia in people with diabetes and differing kidney function are few, and their results conflicting; low kidney function has been associated with hospital-requiring hypoglycaemia in elderly people with diabetes,(21) and with overall hypoglycaemia in recently hos…”
BackgroundResultSGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist
Granata, A. R. M., Pesce, F., Iacoviello, M., Anzaldi, M., Amico, F., Catalano, M. R., Leonardi, G., Gatta, C., Costanza, G., Corrao, S., et al. (2022) · Frontiers in Nephrology · doi:10.3389/fneph.2022.867075 · Cited by 13
“SGLT2i present a low risk of hypoglycemia, a very fearsome and non-infrequent adverse event with some classes of hypoglycemic drugs, especially in people with diabetes with CKD (85).”
BackgroundHong, S., Han, K., & Park, C. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.06.010 · Cited by 11
“In addition, in people with T2DM, CKD is a significant risk factor for the development of hypoglycemia.(8,9)”
BackgroundSaygılı, S., Canpolat, N., Sever, L., Çalışkan, S., Atayar, E., & Özaltın, F. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3980-9 · Cited by 10
Clinical Utility of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin
Grunberger, G. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2663 · Cited by 10
Hypoglycaemia in patients with diabetes mellitus and renal impairment
Hettige, T., & Cooper, M. E. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116683082 · Cited by 10
Ahmed, S. B., & Dumanski, S. M. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.06.033 · Cited by 12
Tibaldi, J. M., Mercado, M. E., & Strong, J. L. (2020) · Clinical Diabetes · doi:10.2337/cd20-0014 · Cited by 10
“” He was also cognizant of the increased risk of hypoglycemia associated with prandial insulin and with his renal insufficiency status (47).”
BackgroundFactors Influencing Variations in Hospitalization for Diabetes with Hypoglycemia
Kattan, W., & Wan, T. T. H. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100367 · Cited by 11
Guo, W., Wang, Q., Pan, S., Li, J., Wang, Y., Shu, Y.-H., Chen, J., Wang, Q., Zhang, S., Zhang, X., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30354 · Cited by 9
“arrhythmias, chronic renal disease, and sudden death (Kong et al., 2014; Moen et al., 2009; Zoungas et al., 2010).”
BackgroundWeir, M. R., Gravens-Mueller, L., Costa, N. A., Ivanova, A., Manitpisitkul, W., Bostom, A. G., & Diamantidis, C. J. (2014) · Transplantation · doi:10.1097/tp.0000000000000454 · Cited by 9
“Moreover, a study in diabetic patientswith chronic kidney disease demonstrated increased 1-day mortality in those individuals with reduced GFR experiencing hypoglycemia.(17) However, we did not observe an increased risk of hypoglycemia with the use of these drugs in our lowest estimated GFR tertile group.”
BackgroundSakurai, K., Kawai, Y., Yamazaki, M., & Komatsu, M. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.007 · Cited by 11
“Deterioration of renal function (reduced eGFR) is also known to cause hypoglycemia, especially in insulin and/or insulin secretagogue-treated patients with T2D and chronic kidney disease (CKD).(11,15) Especially, in older users of antihyperglycemic medication, the incidence rate of hypoglycemia was increased with lowe…”
BackgroundHanda, T., Nakamura, A., Miya, A., Nomoto, H., Kameda, H., Cho, K. Y., Nagai, S., Yoshioka, N., Miyoshi, H., & Atsumi, T. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00656-1 · Cited by 10
Frequent hypoglycemia during hemodialysis in ESRD patients leads to higher risk of death
Shi, Y., Wang, T., Ding, Z., Yan, L., Yao, C., & Qian, H. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2484471 · Cited by 9
“…prognosis of patients, and increase the mortality rate, so the prevention and treatment of dialysis complications is particularly important. all major dialysis centers have experienced hypoglycemia during dialysis, there has been growing recognition that esRD is a risk factor of hypoglycemia [3].”
Bajwa, S. J., Sehgal, V., Khaira, U., Sehgal, R., & Bajaj, A. (2013) · Journal of the Scientific Society · doi:10.4103/0974-5009.120052 · Cited by 10
Uric acid, renal function and risk of hypoglycaemia in Chinese type 2 diabetes patients
Ren, Y., Ji, L., Mu, Y., Hong, T., Ji, Q., Guo, L., Huang, Q., & Yang, X. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2809 · Cited by 8
“that CKD was associated with increased risks of hypoglycaemia among subjects with or without diabetes [14].”
BackgroundEffect of Insulin Resistance in Chronic Kidney Disease
Frankel, A., & Kazempour Ardebili, S. (2016) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000255 · Cited by 8
“Reduced clearance of insulin and its prolonged half-life in the CKD population have been reported to lead to reduced insulin requirements and increased hypoglycemic episodes [107-109].”
BackgroundPanduru, N. M., Nistor, I., Groop, P., Biesen, W. V., Farrington, K., & Covic, A. C. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx021 · Cited by 10
Management of Diabetic Nephropathy in Older Patients: A Need for Flexible Guidelines
Abdelhafiz, A. H., Nahas, M. E., & Oliveira, J. M. F. D. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2794 · Cited by 9
Chow, F. C., Chan, S.-P., Hwu, C., Suwanwalaikorn, S., Wu, A., Yu-Gan, S., & Zacarias, M. B. (2012) · Journal of Diabetes Investigation · doi:10.1111/jdi.12006 · Cited by 8
Joly, D. A., Choukroun, G. J., Combe, C., Dussol, B., Fauvel, J., Halimi, J., Quéré, S., & Fiquet, B. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.029 · Cited by 8
“Among them, increasing attention is being given to hypoglycemia [3,4].”
BackgroundPatient safety in chronic kidney disease: time for nephrologists to take action
Pippias, M., & Tomson, C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft364 · Cited by 8
Moin, A. S. M., Al‐Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665134 · Cited by 8
“Notably, diabetic kidney disease (DKD), a co-morbidity already associated with increased risk of hypoglycaemia in nonCOVID-19 infected patients due to factors such as reduced insulin clearance and degradation (39, 40), was the co-morbidity most frequently associated with hypoglycaemia during lockdown (37).”
BackgroundSaygılı, S., Canpolat, N., Sever, L., Çalışkan, S., Atayar, E., & Özaltın, F. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3982-7 · Cited by 8
Carbohydrate Metabolism in Kidney Disease and Kidney Failure
Ritz, E., Adamczak, M., & Więcek, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00002-3 · Cited by 10
Tuttle, K. R., & McGill, J. B. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13986 · Cited by 8
“In particular, advanced CKD is an important risk factor for hypoglycaemia, as gluconeogenesis by the kidney is impaired.(21) In addition, hepatic glycogenolysis and gluconeogenesis are reduced in advanced CKD.”
BackgroundMauricio, D., Gourdy, P., Bonadonna, R. C., Freemantle, N., Bigot, G., Mauquoi, C., Ciocca, A., Bonnemaire, M., & Müller‐Wieland, D. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01031-z · Cited by 8
“Gla-300 dose increase throughout the 24-week treatment period, but are consistent with the higher risk for hypoglycaemia reported in people with CKD [9, 20].”
BackgroundCarbohydrate metabolism in chronic renal disease
Adamczak, M., Ritz, E., & Więcek, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00005-7 · Cited by 9
The Kidney as a Treatment Target for Type 2 Diabetes
Dokken, B. B. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.1.29 · Cited by 9
Risk Factors for Hypoglycemia During Treatment of Hyperglycemic Crises
Ross, R. C., Vadakkel, N., Westmoreland, K., Hendrickson, A. L., Balazh, J. R., Telford, E. D., & Franck, A. J. (2022) · Diabetes Spectrum · doi:10.2337/ds21-0094 · Cited by 8
Consideration of ICD-9 Code-Derived Disease-Specific Safety Indicators in CKD
Hartley, I. R., Ginsberg, J. S., Diamantidis, C. J., Zhan, M., Walker, L. D., Rattinger, G. B., & Fink, J. C. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12671212 · Cited by 7
“Indeed, clinical events included in the CKD PSIs relate to common clinical complications of CKD and have a likely association with adverse outcomes, which was previously shown for hypoglycemia and hyperkalemia (21,22); however, the diverse array of CKD PSIs requires additional validation for their linkage to processes…”
BackgroundSelf-citationJeddi, S., Gheibi, S., Kashfi, K., & Ghasemi, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119870 · Cited by 7
Lapses in safety in end‐stage renal disease patients admitted to surgical services
Harel, Z., Wald, R., Liu, J. J., & Bell, C. M. (2011) · Hemodialysis International · doi:10.1111/j.1542-4758.2011.00633.x · Cited by 7
Ishikawa-Tanaka, T., Hosojima, M., Kabasawa, H., Kaseda, R., Yasukawa, R., Yata, Y., Kuwahara, S., Kono, E., Takata, T., Iino, N., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00928-5 · Cited by 7
Lim, S. J., Moon, J.-Y., Jeong, K. H., Ko, G. J., Choi, Y., & Hwang, H. S. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13601 · Cited by 7
“31 In this study, we expected that the FBG level associated with the lowest mortality would be higher in patients with PD than in those without renal impairment.”
BackgroundShimizu, Y., Nakazato, M., Sato, S., Koyamatsu, J., Yamanashi, H., Nagayoshi, M., Kadota, K., Hayashida, N., Yamasaki, H., Kusano, Y., et al. (2015) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-015-0054-6 · Cited by 6
“Since another study reported that chronic kidney disease is a risk factor for hypoglycemia (<70 mg/dL) and this association was observed both in subjects with or without diabetes [21], those with reduced GFR may demonstrate a frequency of hypoglycemia that results in lower HbA1c levels.”
BackgroundBrath, H., Paldánius, P. M., Bader, G., & Mathieu, C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0276-1 · Cited by 6
“Both groups often have prolonged duration of type 2 diabetes in general and are more vulnerable to adverse side effects, especially hypoglycemia [19].”
BackgroundA New Perspective to Longstanding Challenges with Outpatient Hyperkalemia: A Narrative Review
Chiu, M., Garg, A. X., MOIST, L. M., & Jain, A. K. (2023) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581221149710 · Cited by 6
Fitzpatrick, J. K., Parikh, R., Hamilton, S. A., Ambrosy, A. P., Tan, T. C., Bansal, N., Go, A. S., for the CRIC Study Investigators, Appel, L. J., Chen, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35440-w · Cited by 6
CE: Improving Outcomes for Patients with Chronic Kidney Disease Part 1
Norton, J. M., Newman, E. P., Romancito, G., Mahooty, S., Kuracina, T. A., & Narva, A. S. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000512272.33956.8b · Cited by 6
Migdalis, I. N., Παπάνας, Ν., Ioannidis, I., Sotiropoulos, A., Raptis, A. E., Dimitriadis, G., & (HDNS), O. B. O. T. H. D. N. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102104 · Cited by 7
“In a retrospective analysis of 240,000 subjects, the incidence of hypoglycemia was higher in patients with versus without DCKD and the odds of mortality were increased at all levels of hypoglycemia, constituting a significant threat [24].”
BackgroundAragón‐Sánchez, J., Víquez‐Molina, G., López‐Valverde, M. E., Rojas‐Bonilla, J. M., & Murillo‐Vargas, C. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0072 · Cited by 6
“41 This is consistent with our research, since the group with HbA1c 7% had lower values of eGFR, which could play an additional role in the occurrence of hypoglycemia in that group.”
Glycemic control in diabetic kidney disease patients
Yadav, S. C. (2012) · Clinical Queries Nephrology · doi:10.1016/s2211-9477(12)70002-x · Cited by 6
Finding a Common Language for Patient Safety in CKD
Fink, J. C., Joy, M. S., Peter, W. L. S., & Wahba, I. M. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12781211 · Cited by 6
Self-citationManaging Diabetes From First Diagnosis
Kruger, D. (2012) · The diabetes educator · doi:10.1177/0145721712450619 · Cited by 3
Busch, M., Lehmann, T., Wolf, G., Günster, C., Müller, U. A., & Muller, N. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1129-6699 · Cited by 7
Hsu, C., Wen, M., Chiu, H., Tsai, S., Yu, T., Yang, C., Wu, M., & Chen, C. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02132-w · Cited by 6
Sulfonylurea derivatives and risk of hypoglycaemia in type 2 diabetic patients
Svěcený, J., Jirušková, J., Hrach, K., Radovnická, L., & Laštůvka, J. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.114 · Cited by 6
“Ta je celosvětově nejčastěji způsobena právě diabetem mellitem a je považována za významný rizikový faktor hypoglykemie obecně (tedy i u nediabetiků), avšak přítomnost diabetu mellitu (a tedy i volba medikace) signifikantně zvyšuje toto riziko se všemi důsledky (45).”
Glucose lowering therapies for chronic kidney disease and kidney transplantation
Jun, M., Lo, C., Badve, S. V., Pilmore, H., White, S. L., Hawley, C. M., Cass, A., Perkovic, V., & Zoungas, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966 · Cited by 6
Lee, D. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0165 · Cited by 6
Song, S. H., & Frier, B. M. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15170 · Cited by 5
“73m(2).(11) The eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation defined as:”
MethodChen, J., Chan, M., Fan, P., Tsai, T.-Y., Yen, C., Hsiao, C.-C., Lee, C., Lin, C., Chen, Y., Yang, C.-W., et al. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.12.007 · Cited by 5
Ferhatbegović, L., Bećirović, M., Bečirović, E., Sarajlić, S., Ribić, A., Šarić, A., Bećirović, A., & Pojskić, B. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1765597 · Cited by 5
Song, S. H., & Frier, B. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15466 · Cited by 5
Chu, P. Y., Edmondson, E. K., Flory, J., Huang, J., & Hennessy, S. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3530 · Cited by 6
“20,21 Because renal dysfunction can confound the relationship between ACEI exposure and hypoglycemia, increasing both hypoglycemia risk and the probability of ACEI prescription, it can lead to upwardly biased measures of association.”
CE: Improving Outcomes for Patients with Chronic Kidney Disease Part 2
Norton, J. M., Newman, E. P., Romancito, G., Mahooty, S., Kuracina, T. A., & Narva, A. S. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000513259.90613.27 · Cited by 6
de Lucas, M. D. G., Olalla, J., & Avilés, B. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13098 · Cited by 5
Rokicka, D., Marek, B., Kajdaniuk, D., Wróbel, M. P., Szymborska‐Kajanek, A., Ogrodowczyk-Bobik, M., Urbanek, A., Janyga, S., Borgiel−Marek, H., & Strojek, K. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2019.0020 · Cited by 10
When ESKD complicates the management of diabetes mellitus
William, J. H., Morales, A., & Rosas, S. E. (2020) · Seminars in Dialysis · doi:10.1111/sdi.12873 · Cited by 6
Abdelhafiz, A. H. (2009) · Wiley eBooks · doi:10.1002/9780470744093.ch5 · Cited by 5
Adult Nesidioblastosis in Chronic Kidney Disease
Lozano-Melendez, E., Aguilar-Soto, M., Graniel-Palafox, L., Ceceña-Martínez, L., Valdez-Ortiz, R., & Solis-Jiménez, F. (2019) · Case Reports in Endocrinology · doi:10.1155/2019/7640384 · Cited by 6
Incidence and Predictors of Dysglycemia in Intensive Care Unit Patients: A Cohort Study
Nielsen, C. G., Olsen, M. T., Pedersen‐Bjergaard, U., Schønemann‐Lund, M., Johansson, P. I., Kristensen, P. L., & Bestle, M. H. (2025) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.70149 · Cited by 4
“We identified CKD and AKI as predictors of hypoglycemia 3.9 mmol/L, and CKD as a predictor of hypoglycemia 3.0 mmol/L. CKD is a known risk factor for hypoglycemia in outpatients, which may be due to decreased renal gluconeogenesis and reduced clearance of insulin [40, 41].”
InfluentialSullivan, S. D., Freemantle, N., Gupta, R. A., Wu, J., Nicholls, C. J., Westerbacka, J., & Bailey, T. S. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.306 · Cited by 4
Sloan, L. A., CHENG, A. Y. Y., Escalada, J., Haluzík, M., & Mauricio, D. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15425 · Cited by 4
“17 This heightened risk is seen in continuous glucose monitoring (CGM) data in people with T2D and eGFR 45 ml/min/1.73 m 2 (n = 80).”
BackgroundInfluentialManaging diabetes in hospitalized patients with chronic kidney disease
Iyer, S. N., & Tanenberg, R. J. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.14189 · Cited by 4
Kabasawa, H., Hosojima, M., Kanda, E., Nagai, M., Murayama, T., Tani, M., Kamoshita, S., Kuroda, A., & Kanno, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311671 · Cited by 4
Managing Diabetes in Patients With Diabetes of Long Duration
Triplitt, C. (2012) · The diabetes educator · doi:10.1177/0145721712449390 · Cited by 4
“However, patients with CKD are at high risk of hypoglycemia, with or without the presence of diabetes (see Figure 1).(16) Concern about the risks of hypoglycemia can adversely affect treatment success for patients with T2DM.”
BackgroundIn-Silico Trials for Glucose Control in Hospitalized Patients with Type 2 Diabetes
Choi, K., Oh, T. J., Lee, J. C., Kim, M.-J., Kim, H. C., Cho, Y. M., & Kim, S. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.2.231 · Cited by 5
“Several reasons for this effect have been suggested, including reduced insulin clearance, reduced gluconeogenesis, and increased risk of gastroparesis in patients with renal insufficiency (22-24).”
BackgroundMori, K., Emoto, M., Numaguchi, R., Yamazaki, Y., Urata, H., Motoyama, K., Morioka, T., Shoji, T., & Inaba, M. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.133 · Cited by 4
Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?
Molitch, M. E. (2017) · American Journal of Nephrology · doi:10.1159/000485844 · Cited by 4
Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study
Alão, S., Conceição, J., Dores, J. M., Santos, L. D. C., Araújo, F., de Pape, E. A., Reis, M., Chipepo, Á., Nascimento, E., Baptista, A., et al. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-020-00114-3 · Cited by 4
“The confluence of these factors may contribute to a greater risk for hypoglycemia among patients with CKD and may be an unintended consequence of therapy to treat hyperglycemia in these patients [32].”
BackgroundKhaliq, A., Chughtai, M. F. J., Iqbal, J., Nawaz, H., Ahsan, S., Mehmood, T., Liaqat, A., Nadeem, M., Sameed, N., Saeed, K., et al. (2021) · Springer eBooks · doi:10.1007/978-3-030-76320-6_16 · Cited by 4
Management of type 2 Diabetes in patients with Chronic Kidney Disease
Bansal, B. (2017) · Archives of Clinical Nephrology · doi:10.17352/acn.000026 · Cited by 4
“The odds of 1day mortality were increased at all levels of hypoglycemia (6).”
BackgroundNavarro-Blackaller, G., Benítez-Rentería, A. S., Hernández-Morales, K., Rico-Fontalvo, J.-E., Daza-Arnedo, R., Gómez-Ramírez, G. G., Camacho-Guerrero, J. R., Pérez-Venegas, M. A., Carmona-Morales, J., Gonzalez, A. N. O., et al. (2025) · International Journal of Endocrinology · doi:10.1155/ije/9919963 · Cited by 4
McGown, P. J., Papanikolaou, N., El-Taraboulsi, J., Britton, C., Iqtidar, J., Chaudhry, K., Ng, S., Jethwa, K., Patel, J., Reed, J., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70174 · Cited by 3
Carbohydrate Metabolism in Chronic Kidney Disease
Bhattacharya, S. (2018) · JOJ Urology & Nephrology · doi:10.19080/jojun.2018.05.555662 · Cited by 3
Metformin in advanced chronic kidney disease: are current guidelines overly restrictive?
Cole, N. I., Swift, P. A., Suckling, R., & Andrews, P. (2016) · British Journal of Diabetes · doi:10.15277/bjd.2016.106 · Cited by 3
Tubular Secretory Clearance Is Associated With Whole-Body Insulin Clearance
Huber, M. P., Zelnick, L. R., Utzschneider, K. M., Kahn, S. E., de Boer, I. H., & Kestenbaum, B. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa522 · Cited by 4
Kidney Diseases in the Elderly
So, S., Stevenson, J. K., & Lee, V. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-96998-5_16 · Cited by 4
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
Harris, S. B., Parente, E. B., & Karalliedde, J. J. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01247-7 · Cited by 3
“For example, the risk of hypoglycaemia can be approximately twofold higher in those with chronic kidney disease [20] and 1.”
BackgroundLiniger, Z., Ellenberger, B., & Leichtle, A. B. (2022) · Diagnostics · doi:10.3390/diagnostics12123148 · Cited by 3
“, urea), potassium rises in a stage of severe malfunction of the kidney [20].”
BackgroundAbdelhafiz, A. H., & Sinclair, A. J. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch72 · Cited by 3
Older people with diabetes – avoiding hospitalization
Abdelhafiz, A. H., Russell, J., Key, A., & Sinclair, A. J. (2015) · Diabetes Management · doi:10.2217/dmt.15.15 · Cited by 4
Hirose, T., Odawara, M., Matsuhisa, M., Koshida, R., Senda, M., Tanaka, Y., & Terauchi, Y. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108647 · Cited by 3
“[11] Moen MF, Zhan M, Hsu VD,Walker LD, Einhorn LM, Seliger SL, et al.”
BackgroundDiabetes and Kidney disease: metformin
Gnudi, L., & Ricciardi, C. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_24 · Cited by 3
Metadata
- Authors
- Moen, M. F., Zhan, M., Hsu, V. D., Walker, L. D., Einhorn, L. M., Seliger, S. L., & Fink, J. C.
- Affiliations
- University of Maryland, Baltimore (US)
- Corresponding author
- Fink, Jeffrey C.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-06
- Volume
- 4
- Issue
- 6
- Pages
- 1121-1127
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2689888
- OpenAlex
- W2146702281
- Semantic Scholar
- 6dd714ce42c6670e1867d104de400f22b50a7e1c
- Cited by
- 423
- References
- 18
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 28 · 2021: 32 · 2020: 47 · 2019: 31 · 2018: 37 · 2017: 26 · 2016: 27 · 2015: 36 · 2014: 26 · 2013: 23 · 2012: 19
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK075675)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- hypoglycemia, chronic kidney disease, diabetes mellitus, mortality, incidence, estimated glomerular filtration rate, veterans, patient safety, glucose monitoring
- MeSH terms
- Aged, Blood Glucose, Diabetic Nephropathies, Female, Glomerular Filtration Rate, Humans, Hypoglycemia, Male, Middle Aged, Retrospective Studies, Risk Factors, Comorbidity, Incidence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.